Dermapharm Holding SE
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 272.1M 302.4M 290.7M 311.6M
Cost of revenue 88.0M 103.2M 97.5M 115.2M
Gross profit 184.1M 199.2M 193.2M 196.4M
Operating expense
Research & development
Selling general and admin
Other operating expenses 49.2M 49.3M -75.3M 49.6M
Operating income 44.5M 59.8M 45.7M 66.1M
Non operating interest income
Income 1.3M 2.4M -608K 5.3M
Expense 13.2M 12.9M 11.5M 17.9M
Other income expense
Pretax income 32.5M 49.7M 34.6M 46.8M
Tax provision 11.6M 16.5M 15.5M 14.0M
Net income 20.9M 33.2M 19.0M 32.8M
Basic EPS 0.4 0.6
Diluted EPS 0.4 0.6
Basic average shares 53.6M 53.9M
Diluted average shares 53.6M 53.9M
EBITDA 66.1M 82.5M 72.2M 85.5M
Net income from continuing op. 32.5M 49.7M 34.6M 46.8M
Minority interests 2K 208K 1.5M -376K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 59 minutes

07:00
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).